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Introduction
In recent years, common diseases have been increasing in 
developed countries and also developing countries. It has been 
necessary to maintain a patient-oriented standpoint and respond the 
situation in any clinic and hospital.1 Furthermore, to take appropriate 
management for the patients with various diseases and health 
problems in daily clinical care.2 The authors have continued adequate 
medical practice in a wide range of fields in our hospital.3 They 
include Atherosclerotic Cardiovascular Disease (ASCVD), chronic 
heart failure (CHF), chronic kidney disease (CKD), cerebrovascular 
accident (CVA), metabolic syndrome, diabetes, and others.4,5 
Among them, edema has been common symptom and sign, 
which is widely observed in patients with various disease states. The 
pathophysiological causes include cardiovascular, renal, hormonal, 
metabolic, neurological, nutritional factors and so on.6 The definition 
of edema would be a palpable swollen lesion on the body that is 
produced from some expansion of the fluid volume in the interstitial 
tissue. The fluid accumulation in the interstitial tissue may be brought 
from the increased capillary filtration of the fluid taken out related 
to lymphatic drainage.7 If edema occurs in generalized and massive 
degree, it has been called anasarca. Such situation can be found 
from various clinical situations including renal failure, heart failure, 
impaired function of lymphatic system. In clinical practice, edema 
may be usually apparent, when the amount of interstitial volume 
becomes more than 2.5 to 3 liters.8 
Patients with primary hypothyroidism are commonly found in 
clinical practice and are often treated in lots of clinics and hospitals. 
However, clinical cases which are related to serous exudate are rarely 
seen in routine practice.9 The organs detected effusions are observed 
in pericardial effusion, pleural effusion, ascites, and generalized 
portions of face, trunk, and extremities.10 
During our actual daily practice of medicine, we have experienced 
a meaningful and interesting case. The patient was an elderly female, 
and developed subacute anemia of unknown cause. After several 
weeks of treatment, she developed generalized edema and heart 
failure. A further hormonal evaluation revealed the presence of 
hypothyroidism, in which related symptoms and signs were alleviated 
by administration of thyroid hormone. Her clinical progress and some 
discussions will be described in this article. 
Case presentation
Medical history 
The patient was an 85-year-old female who was previously on 
medication for hypertension and atrial fibrillation (Af) for years. 
She has continued regular life without particular accident or medical 
or health problems. As to the past history, she has not detected to 
have diabetes, dyslipidemia, hyperuricemia, metabolic syndrome, 
locomotive syndrome, or cerebrovascular, respiratory gastrointestinal 
diseases. 
She has visited outpatient clinic and has received regularly general 
blood tests for every six months. From Aug 2017, the value of 
hemoglobin has been stable from 11.2g/dL to 12.3g/dL. Examination 
in Sept 2020 showed a sudden drop in Hb level from 11.2g/dL to 
5.2g/dL and MCV from 88fL to 64fL. In this regard, she did not 
feel any particular physical changes such as fatigue or palpitations. 
Furthermore, she also had no unusual episodes, such as changes in her 
stools, nausea, abdominal pain, or other symptoms.
Therefore, the existence of gastrointestinal (GI) bleeding was 
suspected and further evaluation was immediately started. First, fecal 
occult blood was negative in twice. Next, we planned endoscopy of 
the upper gastrointestinal tract. The patient was formerly working as 
a nurse, and she currently hopes to prioritize her life policy compared 
to medical scrutiny. Then, we have explained the necessary reason 
of examination many times. At last, she obeyed the recommendation 
Endocrinol Metab Int J. 2021;9(2):38‒42. 38
©2021 Kondo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which 
permits unrestricted use, distribution, and build upon your work non-commercially.
Generalized edema and heart failure caused from 
hypothyroidism and ferrous agent for hypochromic 
anemia
Volume 9 Issue 2 - 2021
Naoki Kondo,1 Hiroshi Bando,1,2,3 Shigeki 
Hatakeyama,1 Junji Morita,1 Kazuki 
Sakamoto,1 Tomoya Ogawa,1 Noboru 
Iwatsuki1
1Sakamoto Hospital, Higashi Kagawa city, Kagawa, Japan
2Tokushima University/Medical Research, Tokushima, Japan
3Japan Low Carbohydrate Diet Promotion Association, Kyoto, 
Japan 
Correspondence: Hiroshi Bando, MD, PhD, FACP, Tokushima 
University /Medical Research, Nakashowa 1-61, Tokushima 770-
0943 Japan, Tel +81-90-3187-2485, 
Email 
Received: April 13, 2021 | Published: May 03, 2021
Abstract
The patient was an 85-year-old female who has been treated for hypertension and atrial 
fibrillation (Af). She has visited outpatient clinic and has received regularly general blood 
tests for every six months. Hemoglobin (Hb) level was stable as 11.2-12.3 g/dL and MCV 
88fL from 2017, but it decreased suddenly to 5.2 g/dL and 64 fL in Sept 2020. She did 
not feel any symptoms or signs. Further evaluations revealed that occult blood in stool 
and upper and endoscopic exams were negative. About 40 days after starting sodium 
ferrous citrate, she developed edema anasarca, bilateral pleural effusion and heart failure. 
Laboratory test showed hypothyroidism, and then the administration of thyroid hormone 
and diuretics brought her early improvement. As to this impressive case report, general 
clinical progress and some discussion of the relationship among anemia, edema anasarca, 
heart failure and hypothyroidism would be described. 
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and received the endoscopic examinations of upper and lowers 
gastrointestinal tracts. Mild gastroesophageal reflux disease (GERD) 
was noted, but no suspicious bleeding lesions were detected in upper 
and lower GI tracts. No significant changes were observed in the 
abdominal CT. For pulse wave test, ABI was normal 1.15 and 1.09 
bilaterally. From the above, the cause of acute onset bleeding was not 
clarified. Consequently, sodium ferrous citrate (SFC) (FerromiaR) 50 
mg 1T and rebamipide (MucostaR) 100mg 1T/day were started as the 
treatment of hypochromic anemia from late Dec 2020.
She developed fatigue and anasarca from the end of Jan 2021, and 
visited our clinic in early Feb 2021. She did not complain of chest 
discomfort or dyspnea on exertion. 
Physical and laboratory examination findings
Examination revealed severe edema throughout the body, including 
the face and extremities. Atrial fibrillation (Af) and lower voltage 
findings were observed on the electrocardiogram (ECG) (Figure 1). 
SpO2 was 98-99%. Chest XP showed moderate pleural effusion in 
both lungs associated with bilateral vague cost-phrenic angles, which 
was much different from the previous X-P (Figures 2a, 2b). Based on 
the above, she was diagnosed with an acute exacerbation of chronic 
heart failure and was immediately hospitalized. The progress diagram 
of this example described above is shown in Figure 3, which revealed 
the changes in Hb values for recent years.
Figure 1 Electrocardiogram.
Af and low voltage are detected on admission.
Figure 2 Comparison of the chest X-ray. 2a: unremarkable findings in stable 
period on May, 2020, 2b: bilateral pleural effusion in admission on Feb, 2021.
Figure 3 Clinical progress of the case.
Hb level was stable formerly, and increasing now for last few months.
Vitals showed pulse 88/min, BP 146/90 mmHg, BT 36.8 centigrade, 
respiration normal, SpO2 98% in room air, and consciousness was 
alert. Chest showed that no significant murmurs in the heart and 
rather weaker breath sound in the lung. Abdomen revealed flat and 
soft with ordinary bowel sound. No abnormalities were observed in 
neurological examination. 
Laboratory findings on admission and the changes in the data from 
before were summarized in Table 1. Among them, the important results 
included Hb 7.5g/dL, Cr 0.6mg/dL, Na 148mEq/L, K 3.7mEq/L, NT-
Pro BNP 2596pg/mL (-125). When the thyroid function was checked, 
hypothyroidism was found with free T3 1.9ng/mL (2.3-4.3) and TSH 
9.4μIU/mL (0.5-5.0).
The following results were obtained by echocardiography. The 
left ventricular septal diameter (FSD) was 36mm, the left ventricular 
septal diameter (LVSD)/posterior wall diameter (LVPWD) was 
11mm/11mm, the left ventricular diameter shortening rate was 
30%, the left ventricular ejection fraction (LVEF) was 57%, and the 
left ventricular diameter (LVD) was 47mm. As for the findings, no 
abnormality was found in the wall movement of the left ventricle, 
and the contractility of the left ventricle was maintained. Dilation of 
the left bunch is observed. Slight mitral regurgitation (MR) and aortic 
regurgitation (AR) are observed.
Medical problems and Prescription
From the above, the medical problems in this case can be 
summarized as follows. #1 hypertension, #2 Atrial fibrillation 
(Af), mitral regurgitation (MR), aortic regurgitation (AR), #3 acute 
exacerbation of chronic heart failure, #4, hypochromic anemia, #5 
possible bleeding of gastrointestinal tract, #6 hypothyroidism, #7 
Gastroesophageal reflux disease (GERD). After admission, her fatigue 
and edema were improved for short periods by the administration of 
thyroid hormone and diuretics, and she was discharged in a week.
As regards to her medication before the hospitalization, she has 
continued Nifedipine (Adalat CRR) 10mg 1T from spring to summer 
and Nifedipine CR (Adalat CRR) 20 mg 1T from autumn to winter, as 
well as edoxaban tosilate hydrate (LixianaR) 30mg. Concerning the 
medication of Nifedipine, the reason is from her situation that she 
showed lower BP in summer and higher BP in winter. 
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For current hospitalization, her prescription was changed to 
the following and will be continued after discharge. They include 
i) amlodipine besilate (AmlodineR) 5mg 1T, ii) enalapril maleate 
(RenivaceR) 5mg 1T, iii) edoxaban tosilate hydrate (LixianaR) 30mg 1T, 
iv) lansoprazole (TakepronR) 15mg 1T, v) spironolactone (Aldactone 
AR) 25mg 1T, vi) Levothyroxine Sodium Hydrate (Thyradin SR) 25μg, 
vii) tolvaptan (Samska R). 
Clinical progress
This case has remained stable since discharge and has been 
monitored on an outpatient basis. Regarding clinical problems, no 
particular symptoms are observed such as chest discomfort, exertional 
dyspnea, nausea, or abdominal pain. Chest X-P and electrocardiogram 
are also unchanged. Regarding the examination data, improvements 
of the results are found. On discharge, Hb 9.8g/dL and MCV 65.2fL 
were observed, and these data became Hb 11.5g/dL and MCV 79.3fL 
after 7 weeks. For iron metabolism, serum iron levels increased from 
9μg/dL to 118μg/dL, and serum ferritin levels increased from 4.3ng/
mL to 40ng/mL (Table 1).
The overall view of clinical progress in this case is drawn in Figure 
3. The Hb level was temporarily decreased, but it has returned to almost 
the previous level with the administration of iron preparations. She 
was hospitalized and treated, and her fatigue and edema disappeared. 
Currently, she has continued to take ferrous citrate, tolvaptan and 
levothyroxine, with consecutively observing the clinical progress.
Table 1 Changes in several biomarkers
Category Marker Unit
2019 2020 2021
Mar Oct April Sept 5-Nov 14-Nov 4-Feb 8-Feb 16-Feb 2-Mar 30-Mar
CBC WBC (/μL) 4500 5700 6100 5700 6400
RBC (x10*4/μL) 451 416 415 290 356 428 489 519 467
Hb (g/dL) 12.1 11.6 11.2 5.2 5.3 7.5 9.8 10.4 11.3 11.5
Hct (%) 38.9 37 36.3 18.6 19.4 27.9 35.8 35.9 38.6 37.1
MCV (fL) 86 89 88 64 54.5 65.2 73.4 74.4 79.3
MCH (pg) 26.8 27.9 27 17.9 14.8 17.5 19.3 21.2 21.8 24.5
MCHC (g/dL) 31.1 31.4 30.9 28 28.9 29.3 30.9
Plt (x10*4/μL) 32.2 28.3 29.6 36.2 38.7 33.7 28.7 28.8 29.2
Fe Metab Fe (μg/dL) 9 118
UIBC (μg/dL) 392
TIBC (μg/dL) 401
Ferritin (ng/mL) 4.3 40
renal 
function BUN (mg/dL) 12 18 12 14 22 8 16
Cr (mg/dL) 0.7 0.6 0.6 0.6 0.6 0.5 0.7
Na (mEq/L) 141 142 142 142 148 148 144
K (mEq/L) 4.7 4.3 4.6 4 3.7 4.6 4.9
Thyroid free T3 (pg/mL) 1.9 2.7
free T4 (ng/dL) 1.1 1.1




Metab Nutr AST (U/L) 28 31 36 24 42 41 36
ALT (U/L) 15 17 18 11 31 32 28
TP (g/dL) 7.7 7.4 7.5 6.9 7.2 8.1
Alb (g/dL) 4.2 4.2 4.2 3.7 3.7 3.4
HbA1c (%) 5.5 5.2





 TgAB: thyroglobulin antibody, ATMA: Anti thyroid microsomal antibody, TRAb: Anti-TSH receptor antibody     
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Discussion
Regarding this case, a variety of data were obtained. According 
to Table 1, the case did not have remarkable abnormalities in renal 
function, liver function or diabetes. The cause of current anemia was 
not clarified, but the results of CRP, CEA, and endoscopic exams 
suggested that the case was unlikely to have a malignant disease. A 
small dose of thyroid hormone was started, and the values of free 
T3, free T4 and TSH were normalized. Furthermore, improvement of 
anemia seemed to be promoted by the supplementation of thyroid 
hormone (Figure 3). 
In this report, some perspectives will be presented in three main 
aspects. They are i) thyroid function and its supplementation dose, 
ii) relationship among thyroid function, anemia and edema, and iii) 
cardiovascular function and anemia, which are described in order as 
follows.
I suggest connecting the cause of anemia with hypothyroidism, 
as the latter known to cause anemia and the authors may have a 
look at previous studies. In addition, the authors mentioned that the 
hypothyroidism therapy result in improvement of anemia state and 
this may reinforce this suggestion.
Firstly, primary hypothyroidism is more popular than secondary 
hypothyroidism from the genesis point of view. In the case of 
central (secondary and tertiary) hypothyroidism, several causes are 
found such as congenital or acquired hypopituitarism, lymphocytic 
hypophysitis, pituitary apoplexy and other hypothalamic disorders. 
The treatment includes the administration of levothyroxine. The doses 
for replacement for primary hypothyroidism would be 1.6-1.8mg/kg/
day for young to middle-age cases, and that for central hypothyroidism 
is 1.3mg/kg/day with lower required amount.11 In current case, lower 
doses were provided because of higher age and slight reduction of free 
T3 and T4 and slight elevation of TSH value. 
Secondly, she has generalized edema on admission that has been 
called as anasarca. For necessary rapid effective treatment, tolvaptan 
(SamskaR) was provided.12 It is an oral and novel nonpeptide vasopressin 
V2-receptor antagonist, which is used for chronic heart failure (CHF). 
Regarding this agent, a double-blind study was conducted in 254 
subjects for 4 groups. They included placebo, tolvaptan 30mg, 45mg, 
and 60mg provided for 25 days. The results showed weight changes as 
+0.32kg, -0.79kg, -0.96kg, and -0.84kg, respectively with significant 
difference. Clinical efficacy was enough for weight reduction, reduced 
edema, normalized serum sodium level.12 
Recent report showed a female patient with primary 
hypothyroidism, which has bilateral pleural effusion.13 Such case 
associated both of hypothyroidism and pleural effusion has been 
rather rare, and the supplementation of oral levothyroxine tablets 50 
μg per day brought her the improvement of the diseased situation. 
Consequently, physicians had better pay attention to the combination of 
clinical symptoms in order to avoid misdiagnosis and mistreatment.13
Hypothyroidism can bring both possibility of exudative effusion 
or transudative effusion.14 So far, there have been few investigations 
concerning the pathogenesis of pleural effusion from the influence of 
hypothyroidism. Its pathophysiology may be involved in the elevated 
capillary permeability due to the reduced blood values of thyroxine.15 
Previous studies have indicated that thyroid hormone may influence 
the expression of VEGF (vascular endothelial growth factor).16 
Then hypothyroidism may cause elevation of VEGF value in the 
pleural effusion. Hypothyroidism may also bring the rapid increase 
of capillary permeability. On the other hand, administration of 
supplementary oral thyroxine can gradually reduce local VEGF level 
and decrease the amount of pleural effusion.17 This improvement may 
be from the mechanism that VEGF is involved with the regulating 
function of capillary permeability in the case of hypothyroidism.
Further, this case has shown improved anemia after the 
administration of levothyroxine. This response would be the 
correlation between hypothyroidism and anemia.
Thirdly, regarding the combined problems of cardiovascular 
and anemia, some perspectives can be observed.18 In patients with 
heart failure (HF), iron deficiency (ID) may correlate with reduced 
performance of activities of daily living (ADL) and poor health-related 
quality of life (QOL). Oral iron supplementation is not effective for 
iron deficiency patients with HF and reduced ejection fraction. On 
the other hand, intravenous administration of iron therapy would be 
shown to relieve HF symptoms and improve ADL and QOL of the 
patient.18 
Comparing this description with current case in this report, the 
pathophysiological situation seems to be opposite. In this case, there 
were no symptoms or signs of heart failure in the past, and anemia 
was developed for uncertified reason. While the anemia was gradually 
improving after the administration of iron preparations, systemic 
edema was developed. Furthermore, treatment of diuresis after 
admission has improved the anemia in rather short period.
Academic literatures were searched for anemia, edema, anasarca, 
and ferrous citrate as the keywords. As a result, one report suggesting 
these relationships was found.19 The case was 13-month-old girl 
who developed progressive anasarca edema. For several months she 
had consumed large amounts of fresh cow’s milk. On admission, 
severe iron deficiency anemia (IDA) associated with hypochromic 
anemia (Hb3.8g/dL) and reduced ferritin level was found. For further 
evaluation and treatment, absence of allergy for milk and successful 
treatment of intravenous iron sucrose were observed.19 
Some limitations are present in this report. The cause of her 
subacute anemia was investigated, but the endoscopic examination 
and laboratory data were negative. There is a possibility of relationship 
with thyroid function and others. Other medical problems include 
higher age of the patient, and adequate administration of medicines 
for thyroid hormone and cardiovascular control. Our medical team 
will follow up the detail progress with attention. 
In summary, an 85-year-old woman showed an impressive clinical 
progress. In other words, anemia, edema, and heart failure occurred, 
followed by the existence of hypothyroidism clarified, and then 
clinical situation was improved by administration of thyroid hormone. 
Some discussion was described on the relationship among thyroid 
function, edema, cardiac function and anemia. Authors hope that this 
article will serve as a reference for pathophysiological investigations 
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